Napritum (Naproxen)

Naproxen, the active ingredient in Napritum, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for adults with pain, arthritis, dysmenorrhea and gout.

GNH USA supplies Napritum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is used to manage pain and inflammation associated with several musculoskeletal and inflammatory conditions.

- Pain: relief of mild to moderate pain such as headache, dental pain or postoperative discomfort. - Osteoarthritis: reduction of joint pain and stiffness to improve function. - Rheumatoid arthritis: control of inflammatory joint symptoms and swelling. - Dysmenorrhea: alleviation of menstrual cramps. - Gout: management of acute gout attacks.

Adverse reactions may range from mild gastrointestinal discomfort to rare but serious systemic events.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dyspepsia: indigestion or heartburn. - Abdominal pain: cramping or discomfort. - Headache: transient pressure sensation. - Dizziness: light‑headed feeling. - Diarrhoea: loose stools.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening. - Cardiovascular events: increased risk of heart attack or stroke. - Renal impairment: reduced kidney function. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: liver function abnormalities. - Anaphylaxis: acute allergic reaction.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: avoid in patients with active ulcer disease. - Evaluate cardiovascular risk: use lowest effective dose in those with heart disease. - Monitor renal function: caution in patients with chronic kidney disease. - Use lowest effective dose: limit duration to the shortest period needed. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original pack, protect from moisture.

Naproxen can alter the effects of several co‑administered medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, clopidogrel): increased bleeding risk. - Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity. - Lithium: elevated lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential reduction in renal function. - SSRIs (e.g., sertraline): heightened bleeding tendency. - Diuretics (e.g., furosemide): possible decrease in renal clearance of naproxen.